Rein Biotech (002166.SZ): Guangzhou Defu Nutrition will become the controlling shareholder of the company, and trading will resume on December 24th.

Zhitong Finance APP News, Rhine Biotech (002166.SZ) announced that on December 22, 2025, Guangzhou Defu Nutrition Investment Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Guangzhou Defu Nutrition") signed a "Control Rights Change Framework Agreement", "Stock Transfer Agreement", and "Voting Rights Waiver Agreement" with the company's controlling shareholder and actual controller, Mr. Qin Benjun. It was agreed that Mr. Qin Benjun would transfer his 60 million shares of the company (8.09% stake) to Guangzhou Defu Nutrition, waive his voting rights for 189,141,310 shares (25.50% stake), and retain voting rights for 22,248,282 shares (3.00% stake). After the completion of the agreement transfer of shares and the completion of the board of directors reshuffle, Guangzhou Defu Nutrition will become the controlling shareholder of the company, and Ms. Hou Ming and Mr. LI ZHENFU (husband and wife) will become the company's joint actual controllers.